Dramamine Orange Tablet, Chewable
NDC Package 63029-902-01
Package Information
Dramamine Orange (dimenhydrinate) tablets is dimenhydrinate is an antihistamine used to prevent and treat nausea, vomiting and dizziness caused by motion sickness when medication cannot be given by mouth. This formulation utilizes a tablet, chewable delivery system. Marketed by Medtech Products Inc., this product is identified by NDC 63029-902 and is authorized under FDA application M009.
Identification & Billing
- RxCUI: 309913 - dimenhyDRINATE 50 MG Chewable Tablet
- RxCUI: 309913 - dimenhydrinate 50 MG Chewable Tablet
- RxCUI: 602223 - Dramamine 50 MG Chewable Tablet
- RxCUI: 602223 - dimenhydrinate 50 MG Chewable Tablet [Dramamine]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63029 - Medtech Products Inc.
- 63029-902 - Dramamine Orange
- 63029-902-01 - 1 BLISTER PACK in 1 BOX / 8 TABLET, CHEWABLE in 1 BLISTER PACK
- 63029-902 - Dramamine Orange
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (63029-902). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63029-902-01 identifies a specific commercial package of 1 blister pack in 1 box / 8 tablet, chewable in 1 blister pack of Dramamine Orange, a human over the counter drug labeled by Medtech Products Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This tablet, chewable is formulated for oral use and contains dimenhydrinate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Medtech Products Inc. on January 15, 2012. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Dimenhydrinate is an antihistamine used to prevent and treat nausea, vomiting and dizziness caused by motion sickness when medication cannot be given by mouth. Dimenhydrinate injection should not be used in newborns because of an increased risk of side effects.
How is this Medtech Products Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63029090201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.